29.09.2023

Adaptos®Vet goes America (ACVS)

15.09.2023

Adaptos®Vet in ESVOT

12.09.2023

Adaptos®Vet now available in UK and Northern Ireland

03.07.2023

Adaptos®Vet now available in China

05.06.2023

Adaptos®Vet now available in EU

24.05.2023

Biomendex selected into Deep Tech Accelerator program

01.03.2023

Pasi Kankaanpää starts as the CEO of Biomendex on the first of March 2023

06.05.2022

The 1st Distribution Agreement for Adaptos®Vet

11.06.2021

Adaptos® clinical study started with Hospital Orton, Oral and Planmeca

03.05.2021

Biomendex closed 1 M€ investment round

01.09.2020

Biomendex held bone regeneration -seminar

08.04.2020

More functional synthetic bone graft substitutes are developed with reliable porosity analysis and properly chosen analysis methods